Treatment for Sickle Cell Disease

The first patient with Sickle Cell Disease (SCD) has received a transplant of CordIn from Israeli biotech Gamida Cell.  CordIn is an alternative for patients awaiting a suitable match for bone marrow transplants.  Trials of CordIn are planned for patients with aplastic anemia.

http://www.gamida-cell.com/press_item.asp?ID=67&t=Gamida-Cell-Announces-First-Patient-with-Sickle-Cell-Disease-Transplanted-in-Phase-1/2-Study-of-CordIn%E2%84%A2-as-the-Sole-Graft-Source-

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *